黄色在线网址无码|精品久久久噜噜噜久久|国产白嫩护士被弄高潮|一级av毛片免费在线观看|国产精品白丝情趣AV网站|亚洲国产成人久久综合电影|亚洲AⅤ秘 无码一区二区三区|久久人人舔人人爽舔人人AV片

      
      

            
            

              Industry Events
              Roche wins FDA approval for novel diabetes Dx
              Time:2013-05-28 11:07:03     Source:3G Biotech     Readers:

              Roche ($RHHBY) won the FDA's blessing to market a hemoglobin-based diabetes diagnostic, the latest advance in testing for the disease and the first assay of its kind approved in the U.S.

              The Tina-quant HbA1cDx assay charts a patient's average blood sugar levels over the past three months by measuring the percentage of hemoglobin A1c bound to glucose. That information allows physicians to better diagnose diabetes and plot its progression as they manage treatment for patients.

              The test works on Roche's Cobas Integra 800 platform, and the FDA's sign-off allows the company to start selling the test to clinical labs, making it first in line to cash in on U.S. demand for HbA1c testing. As the agency points out, there are tests FDA-cleared for diabetes monitoring, but Roche's offering is the first approved for diagnosis.

              On Roche's heels is Abbott Laboratories ($ABT), which won a CE mark earlier this month for an A1c test of its own, used on the company's Architect diagnostic analyzers. Abbott has filed for FDA approval for the test and is in the meantime rolling it out in in countries across Europe, Asia, Latin America and Africa.

              The head start on sales of an in-demand test could well help Roche's flagging diabetes business. While the company's diagnostics arm hauled in $11.2 billion and a 20% share of the global diagnostics market in 2012, Roche has long struggled with pricing pressures and reimbursement cuts for diabetes.

              In October, Roche announced plans to cut 100 jobs in diabetes and shift the business' diagnostics division to its Indianapolis headquarters while moving the glucose monitor unit to Germany. Now, according to a Reuters report, Roche is exploring the idea of unloading the meter business, meeting with potential suitors in early-stage talks.



              Read more: Roche wins FDA approval for novel diabetes Dx - FierceMedicalDevices http://www.fiercemedicaldevices.com/story/roche-wins-fda-approval-novel-diabetes-dx/2013-05-24#ixzz2UYLlSXcn
              Subscribe at FierceMedicalDevices
              會(huì)員登錄:
              如您忘記密碼,請(qǐng)聯(lián)系我們的客服!
              聯(lián)系電話:400-669-0360
              登陸:
              • 新浪微博登錄
              富民县| 永宁县| 四会市| 宁都县| 朔州市| 宣化县| 舞阳县| 册亨县| 松原市| 中超| 昆明市| 蒙山县| 蓝田县| 本溪市| 牙克石市| 容城县| 绥棱县| 留坝县| 沾化县| 南木林县| 罗城| 江津市| 泰顺县| 吴江市| 莆田市| 富阳市| 武强县| 咸阳市| 大丰市| 报价| 潼南县| 康马县| 锦州市| 玛曲县| 山西省| 嘉善县| 巴林左旗| 乌拉特中旗| 花垣县| 浑源县| 宕昌县|